Merowe Daman Hospital
Khartoum, Sudan
NCT Number: NCT06051526
In Africa, the prevalence of critical illness is likely to be higher due to a greater burden of disease, and the associated mortality higher due to limited resources. This is a prospective, observational study to rapidly establish the prevalence of critical illness in in-hospital adult patients in Africa, and the resources available to provide essential critical care (care that should be available to every patient in the world) and factors associated with mortality. Rapid dissemination of these findings may help mitigate mortality from critical illness in Africa. These points provide the rationale for the African Critical Illness Outcomes Study.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Khartoum, Sudan
STUDY OBJECTIVES
The objectives of this study are to determine:
STUDY DESIGN
An African multi-centre prospective observational cohort study of adult (≥18 years) in-hospital patients. Patient follow up will be for a maximum of 7 days in-hospital.
The primary outcome is in-hospital mortality in adult hospital patients with and without critical illness in Africa.
The intention is to provide a representative sample of the mortality, the risk factors associated with mortality in adult patients with critical illness, and the resources available and interventions provided to treat critical illness in Africa. This study will run between September and November 2023.
PREPARATORY WORK
This study will be run by the African Perioperative Research Group (APORG), with a network of over 600 hospitals in more than 40 African countries which has successfully conducted the African Surgical Outcomes Study (ASOS), the ASOS-2 Trial, the African COVID-19 Critical Care Outcomes Study (ACCCOS) and the African Pediatric Surgical Outcomes Study (ASOS-PEDS).
IMPORTANCE OF THIS STUDY
To decrease the mortality associated with critical illness in Africa, it is important to rapidly establish the potential risk factors for mortality, and resources available to manage these patients. The APORG network has the capacity to provide these data timeously.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 days
The number of participants with critical illness.
Time frame: 7 days
The number of participants with in-hospital mortality (censored at 7-days)
Time frame: 7 days
To number of critically ill patients who receive essential emergency and critical care.
Time frame: 7 days
The length of hospital stay for critically ill patients
Time frame: 7 days
The number of essential emergency and critical care resources available
University of Cape Town
Other
Acronym: ACIOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07656311
Cancer, Critical Illness
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07586254
Critical Illness, Digestive System Diseases
Samsun, Atakum, Turkey (Türkiye)
View Trial DetailsNCT06762184
Critical Illness, Disease Attributes
Beijing, Chile
View Trial DetailsNCT04612348
Critical Illness, Disease Attributes
Columbus, Ohio, United States
View Trial Details